158 related articles for article (PubMed ID: 7983645)
1. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
[TBL] [Abstract][Full Text] [Related]
2. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
3. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
4. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
5. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
8. Spectrum and clinical significance of autoantibodies against transfer RNA.
Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
[TBL] [Abstract][Full Text] [Related]
9. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro/SSA and La/SSB antibodies.
Franceschini F; Cavazzana I
Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
12. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
13. The detection of anti-Ro/SS-A and anti-La/SS-B activity of human serum monoclonal immunoglobulins (monoclonal gammopathies).
Buskila D; Weigl D; Shoenfeld Y
Hum Antibodies Hybridomas; 1992 Apr; 3(2):75-80. PubMed ID: 1633268
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
[TBL] [Abstract][Full Text] [Related]
16. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
18. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different methods for the detection of anti-Ro/SSA antibodies in connective tissue diseases.
Morozzi G; Bellisai F; Simpatico A; Pucci G; Bacarelli MR; Campanella V; Marcolongo R; Galeazzi M
Clin Exp Rheumatol; 2000; 18(6):729-31. PubMed ID: 11138336
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
Zhang FC; Liu L; Xu D
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
